» Articles » PMID: 24398169

Effects of Hydroxylated Resveratrol Analogs on Oxidative Stress and Cancer Cells Death in Human Acute T Cell Leukemia Cell Line: Prooxidative Potential of Hydroxylated Resveratrol Analogs

Overview
Publisher Elsevier
Date 2014 Jan 9
PMID 24398169
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Resveratrol and its higher hydroxylated analogs have been reported to possess a variety of biological properties including antioxidant as well as prooxidant effects. The antioxidant properties are assumed to enable these compounds to protect cells from oxidative damage, however prooxidant activity are held likely to be responsible for their cytotoxic or pro-apoptotic effects. In present study the effects of resveratrol (Res) and its three derivatives: 3,3',4,4'-tetrahydroxy-trans-stilbene (M6), 3,4,4',5-tetrahydroxy-trans-stilbene (M8) and 3,3',4,4',5,5'-hexahydroxy-trans-stilbene (M12) were investigated on T cell leukemia Jurkat cells. The tested compounds have cytotoxic activity against cancer cells and IC50 values obtained in the Alamar blue assay were: 58.4 μM, 48.1 μM, 33.4 μM for and 13.8 μM for Res, M6, M8, M12, respectively. Furthermore, we also observed an increased activity of caspase 3 and 9, with significantly higher values in cells incubated with M8 and M12 than Res and M6. Cell death was accompanied by loss of mitochondrial potential, oxidative stress, decrease of glutathione level as well as loss of both mRNA expression and activity of superoxide dismutase (MnSOD). Cytotoxic activity may be connected with the formation of short-living prooxidative metabolites as compounds M8 and M12 were very instable in incubation medium. In conclusion, we elucidated the mechanisms responsible for cytotoxicity of hydroxylated resveratrol analogs in leukemia cells which may also apply to other polyphenols.

Citing Articles

Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin.

Khanvilkar S, Mittra I Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861193 PMC: 11769567. DOI: 10.3390/ph18010132.


Polyphenolic Nanomedicine Regulating Mitochondria REDOX for Innovative Cancer Treatment.

Yang M, He Y, Ni Q, Zhou M, Chen H, Li G Pharmaceutics. 2024; 16(8).

PMID: 39204317 PMC: 11359087. DOI: 10.3390/pharmaceutics16080972.


Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer.

Cotino-Najera S, Herrera L, Dominguez-Gomez G, Diaz-Chavez J Front Pharmacol. 2023; 14:1287505.

PMID: 38026933 PMC: 10667487. DOI: 10.3389/fphar.2023.1287505.


Green tea extract and hydroxyl-chloroquine combination enhances apoptosis in A549 non-small cell lung cancer cells.

K T, Chidurala R, Parepalli S, Vp K Bioinformation. 2023; 19(8):860-865.

PMID: 37908618 PMC: 10613812. DOI: 10.6026/97320630019860.


Resveratrol Analogues as Selective Estrogen Signaling Pathway Modulators: Structure-Activity Relationship.

Kobylka P, Kucinska M, Kujawski J, Lazewski D, Wierzchowski M, Murias M Molecules. 2022; 27(20).

PMID: 36296565 PMC: 9608462. DOI: 10.3390/molecules27206973.